Perrigo (PRGO) Tax Provisions (2012 - 2026)
Perrigo (PRGO) posted quarterly Tax Provisions of -$18.7 million for Q1 2026, down 328.05% year-over-year from $8.2 million in Q1 2025, and down 122.56% quarter-over-quarter from $82.9 million in Q4 2025.
Perrigo (PRGO) Tax Provisions (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Tax Provisions for 15 consecutive years, with -$18.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions fell 328.05% year-over-year to -$18.7 million; the TTM figure through Mar 2026 stood at $77.6 million (down 59.33% YoY), while the FY2025 annual figure was $104.4 million, up 30.5% from the prior year.
- Tax Provisions fell to -$18.7 million in Q1 2026 per PRGO's latest filing, from $82.9 million in the prior quarter.
- Across five years, Tax Provisions topped out at $111.5 million in Q4 2024 and bottomed at -$102.7 million in Q1 2024.
- Historically, Tax Provisions has averaged $9.0 million across 5 years, with a median of $5.4 million in 2023.
- On a YoY basis, Tax Provisions climbed as much as 936.84% in 2024 and fell as far as 2001.85% in 2024.
- Perrigo's Tax Provisions stood at -$1.6 million in 2022, then slumped by 1562.5% to -$26.6 million in 2023, then surged by 519.17% to $111.5 million in 2024, then dropped by 25.65% to $82.9 million in 2025, then tumbled by 122.56% to -$18.7 million in 2026.
- Business Quant data shows PRGO's Tax Provisions at -$18.7 million in Q1 2026, $82.9 million in Q4 2025, and $9.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 16.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 16.90 Mn |
| Mar 28, 2026 | -18.70 Mn |
| Dec 31, 2025 | 82.90 Mn |
| Sep 27, 2025 | 9.70 Mn |
| Jun 28, 2025 | 3.70 Mn |
| Mar 29, 2025 | 8.20 Mn |
| Dec 31, 2024 | 111.50 Mn |
| Sep 28, 2024 | 39.40 Mn |
| Jun 29, 2024 | 31.70 Mn |
| Mar 30, 2024 | -102.70 Mn |
| Dec 31, 2023 | -26.60 Mn |
| Sep 30, 2023 | 3.80 Mn |
| Jul 1, 2023 | 13.60 Mn |
| Apr 1, 2023 | 5.40 Mn |
| Dec 31, 2022 | -1.60 Mn |
| Oct 1, 2022 | 48.60 Mn |
| Jul 2, 2022 | -43.40 Mn |
| Apr 2, 2022 | -11.70 Mn |
| Dec 31, 2021 | -22.20 Mn |
| Oct 2, 2021 | 442.80 Mn |